The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
- PMID: 25691825
- PMCID: PMC4322527
- DOI: 10.5114/wo.2014.47136
The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
Abstract
The Cancer Genome Atlas (TCGA) is a public funded project that aims to catalogue and discover major cancer-causing genomic alterations to create a comprehensive "atlas" of cancer genomic profiles. So far, TCGA researchers have analysed large cohorts of over 30 human tumours through large-scale genome sequencing and integrated multi-dimensional analyses. Studies of individual cancer types, as well as comprehensive pan-cancer analyses have extended current knowledge of tumorigenesis. A major goal of the project was to provide publicly available datasets to help improve diagnostic methods, treatment standards, and finally to prevent cancer. This review discusses the current status of TCGA Research Network structure, purpose, and achievements.
Keywords: The Cancer Genome Atlas (TCGA); big data analysis; cancer genomics.
Figures

Similar articles
-
A survey and evaluation of Web-based tools/databases for variant analysis of TCGA data.Brief Bioinform. 2019 Jul 19;20(4):1524-1541. doi: 10.1093/bib/bby023. Brief Bioinform. 2019. PMID: 29617727 Free PMC article. Review.
-
The Cancer Genome Atlas Clinical Explorer: a web and mobile interface for identifying clinical-genomic driver associations.Genome Med. 2015 Oct 27;7:112. doi: 10.1186/s13073-015-0226-3. Genome Med. 2015. PMID: 26507825 Free PMC article.
-
TCGA Expedition: A Data Acquisition and Management System for TCGA Data.PLoS One. 2016 Oct 27;11(10):e0165395. doi: 10.1371/journal.pone.0165395. eCollection 2016. PLoS One. 2016. PMID: 27788220 Free PMC article.
-
The 2nd Conference and Workshop of The Cancer Genome Atlas (TCGA) in India: Towards Team Science for Multi-omics Cancer Research in South Asia.Ecancermedicalscience. 2021 May 25;15:ed111. doi: 10.3332/ecancer.2021.ed111. eCollection 2021. Ecancermedicalscience. 2021. PMID: 34221123 Free PMC article.
-
Data mining The Cancer Genome Atlas in the era of precision cancer medicine.Swiss Med Wkly. 2015 Sep 16;145:w14183. doi: 10.4414/smw.2015.14183. eCollection 2015. Swiss Med Wkly. 2015. PMID: 26375999 Review.
Cited by
-
PTPN11 is a potential biomarker for type 2 diabetes mellitus complicated with colorectal cancer.Sci Rep. 2024 Oct 24;14(1):25155. doi: 10.1038/s41598-024-75889-x. Sci Rep. 2024. PMID: 39448762 Free PMC article.
-
Integration of ubiquitination-related genes in predictive signatures for prognosis and immunotherapy response in sarcoma.Front Oncol. 2024 Oct 14;14:1446522. doi: 10.3389/fonc.2024.1446522. eCollection 2024. Front Oncol. 2024. PMID: 39469643 Free PMC article.
-
Classifying Breast Cancer Subtypes Using Deep Neural Networks Based on Multi-Omics Data.Genes (Basel). 2020 Aug 4;11(8):888. doi: 10.3390/genes11080888. Genes (Basel). 2020. PMID: 32759821 Free PMC article.
-
Comprehensive pan-cancer investigation: unraveling the oncogenic, prognostic, and immunological significance of Abelson interactor family member 3 gene in human malignancies.Front Mol Biosci. 2023 Oct 24;10:1277830. doi: 10.3389/fmolb.2023.1277830. eCollection 2023. Front Mol Biosci. 2023. PMID: 37942289 Free PMC article.
-
PAIP2 is a potential diagnostic and prognostic biomarker of breast cancer and is associated with immune infiltration.Front Genet. 2022 Nov 10;13:1009056. doi: 10.3389/fgene.2022.1009056. eCollection 2022. Front Genet. 2022. PMID: 36437922 Free PMC article.
References
-
- Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70. - PubMed
-
- Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature. 1998;396:643–9. - PubMed
-
- The Cancer Genome Atlas homepage. http://cancergenome.nih.gov/abouttcga.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources